Mustang Bio Inc (NASDAQ:MBIO) has a beta value of 1.77 and has seen 12.91 million shares traded in the last trading session. The company, currently valued at $11.09M, closed the last trade at $0.21 per share which meant it lost -$0.01 on the day or -1.92% during that session. The MBIO stock price is -628.57% off its 52-week high price of $1.53 and 38.1% above the 52-week low of $0.13. If we look at the company’s 10-day average daily trading volume, we find that it stood at 35.72 million shares traded. The 3-month trading volume is 7.47 million shares.
The consensus among analysts is that Mustang Bio Inc (MBIO) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
Mustang Bio Inc (NASDAQ:MBIO) trade information
Sporting -1.92% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the MBIO stock price touched $0.21 or saw a rise of 52.15%. Year-to-date, Mustang Bio Inc shares have moved 20.90%, while the 5-day performance has seen it change 16.37%. Over the past 30 days, the shares of Mustang Bio Inc (NASDAQ:MBIO) have changed 12.63%. Short interest in the company has seen 0.37 million shares shorted with days to cover at 0.61.
Mustang Bio Inc (MBIO) estimates and forecasts
Figures show that Mustang Bio Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -53.51% over the past 6 months, with this year growth rate of 86.50%, compared to 16.90% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 18.87% over the past 5 years.
MBIO Dividends
Mustang Bio Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Mustang Bio Inc (NASDAQ:MBIO)’s Major holders
Insiders own 7.48% of the company shares, while shares held by institutions stand at 5.72% with a share float percentage of 6.19%. Investors are also buoyed by the number of investors in a company, with Mustang Bio Inc having a total of 32.0 institutions that hold shares in the company.
